• Mashup Score: 5

    This Special Communication examines the current landscape of health care coverage for undocumented immigrants in the US, characterizes state-level differences in emergency Medicaid eligibility and coverage, and presents strategies to address coverage gaps.

    Tweet Tweets with this article
    • Special Communication: Undocumented immigrants in the US have restricted access to health care due to federal limitations, with states providing differing levels of emergency-focused coverage subject to budget and political constraints. https://t.co/gETIUuRpuW @TrishaSantosMD https://t.co/5p3Hqmmj3X

  • Mashup Score: 11

    This Review summarizes current evidence on colorectal, pancreatic, and esophagogastric cancers among individuals aged 18 to 49 years.

    Tweet Tweets with this article
    • From @JAMA_current: Early-onset gastrointestinal cancers are among the largest subset of early-onset cancers globally. This JAMA Review summarizes current evidence on early-onset gastrointestinal cancers. https://t.co/fKFuphZcD1 @KimmieNgMD @DanaFarber https://t.co/8lGw697DAr

  • Mashup Score: 42

    This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.

    Tweet Tweets with this article
    • Most viewed this week from @JAMAInternalMed: Patient Page covers #GLP1 weight-loss medications, focusing on food craving reduction, blood glucose control, dietary strategies, exercise for muscle retention, and lifestyle changes to prevent weight regain. https://t.co/gGNGwWoB1X https://t.co/JIZVYc28WL

  • Mashup Score: 3

    This Viewpoint discusses new Women’s Preventive Services Initiative breast cancer screening recommendations encompassing the entire clinical pathway from screening to diagnosis.

    Tweet Tweets with this article
    • Viewpoint: The Women's Preventive Services Initiative recommends expanded coverage and patient navigation for breast cancer screening to improve effectiveness and accessibility. https://t.co/tGe13gYgW3 https://t.co/qiA6dYlQYx

  • Mashup Score: 5

    This JAMA Clinical Guidelines Synopsis summarizes the 2024 Kidney Disease: Improving Global Outcomes (KDIGO) recommendations for management and delaying progression of chronic kidney disease (CKD) in adults.

    Tweet Tweets with this article
    • Global prevalence of chronic kidney disease (CKD) is approximately 9%, and patients with CKD are at increased risk of morbidity and mortality. Read this @JAMA_current summary of the 2024 KDIGO recommendations for managing CKD in adults. https://t.co/WC7lmpBkv4 https://t.co/Y1q4DCrGvE

  • Mashup Score: 7

    This case report describes a man in his 60s who presented with a 3-day history of low-grade, intermittent fever, myalgia, and headache, along with episodes of blurred vision and recurrent syncope.

    Tweet Tweets with this article
    • This case report describes a man in his 60s who presented with a 3-day history of low-grade, intermittent fever, myalgia, and headache, along with episodes of blurred vision and recurrent syncope. https://t.co/twuApR75J7 https://t.co/4EmfFYeFBK

  • Mashup Score: 3

    This cross-sectional study compares US Food and Drug Administration–approved anticancer “me-too,” or next-in-class, drugs with randomized clinical trial comparators of first-in-class drugs.

    Tweet Tweets with this article
    • Among FDA anticancer drug approvals from 2009 to 2020, only 27 next-in-class drugs had direct randomized clinical trial comparisons with first-in-class drugs. https://t.co/qSkYe4E6Cm @Timothee_MD @ManniMD1 https://t.co/2UQzV8L2mE